QGEN · NYSE · Medical - Diagnostics & Research

QIAGEN

Supplies sample technologies, molecular diagnostics, PCR and genomics tools for research and clinical testing.

$43.00
After-hours close−0.12 (−0.28%)
At close$43.12(−1.42%)

Breakdown13F · Form 4

Institutions 70.85%Insiders

Shares outstanding 206.25M · Float 204.78M · 99.3% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Wellington Management Group LLP12.41M6.02%13FAug 14, 2026
Price T Rowe Associates Inc /MD/11.35M5.51%13FAug 14, 2026
Principal Financial Group Inc6.65M3.22%13FAug 4, 2026
Vanguard Capital Management LLC6.21M3.01%13FAug 13, 2026
BlackRock, Inc.5.91M2.86%13FAug 7, 2026

Institutions13F, as of Jun 30, 2026

362 holders · 146.13M shares · 74 new positions · 209 increased · 97 reduced · 81 closed

HolderShares% outstandingChg q/qFiled
Wellington Management Group LLP12.41M6.02%−1.96MAug 14, 2026
Price T Rowe Associates Inc /MD/11.35M5.51%+2.93MAug 14, 2026
Principal Financial Group Inc6.65M3.22%+6.64MAug 4, 2026
Vanguard Capital Management LLC6.21M3.01%+103.6KAug 13, 2026
BlackRock, Inc.5.91M2.86%+655.2KAug 7, 2026
Morgan Stanley5.04M2.44%+851.5KAug 13, 2026
Earnest Partners LLC4.57M2.22%+705.0KAug 13, 2026
Goldman Sachs Group Inc4.44M2.15%+3.05MAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Massachusetts Financial Services Company11.60%13GMay 14, 2025
BlackRock, Inc.10.20%Nov 7, 2024
Wellington Group Holdings LLPincl. Wellington Management Group LLP, Wellington Management Company LLP +1 more9.49%13GNov 8, 2024
Wellington Management Group LLP6.50%14.14M13GFeb 10, 2026

InsidersForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.